TAK-875 (fasiglifam)

fasiglifam · Takeda Pharmaceutical Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAK-875 (fasiglifam), covering 2013-03-22 to 2013-03-22. Get the full timeline:

Most recent: Clinical Trial Update: Open-label Study of TAK-875 [Phase 3]